News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

W. L. Gore & Associates, Inc. Appeals $860 Million Loss To C.R. Bard


12/13/2013 9:00:25 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

W.L. Gore & Assoc. appeals its $860 million patent infringement loss to C.R. Bard over stent graft technology. C.R. Bard (NYSE:BCR) had no standing to bring the patent infringement lawsuit that won it a nearly $860 million verdict against W.L. Gore & Assoc., Gore argued in its appeal yesterday. Gore, which has already begun paying out the $857.4 million it owes for infringing a Bard stent graft patent, filed its appeal with the U.S. Court of Appeals for the Federal Circuit Dec. 11.

Help employers find you! Check out all the jobs and post your resume.

Read at MassDevice


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES